MGMA submitted comments to the Substance Abuse and Mental Health Services Administration (SAMHSA) in response to the agency’s proposal to modify the privacy requirements for sharing substance use disorder (SUD) information. SAMHSA proposed a number of modifications to current regulations that could impact medical group practices. Patients would be required to designate a practice, as opposed to a specific individual as currently required, to receive their SUD information, which MGMA supports. While MGMA expressed support for practice access to SUD information in emergency situations and to all state Prescription Drug Monitoring Program (PDMP) information, we expressed concern that certain non-clinicians, including law enforcement officials, could be given access to SUD and other sensitive patient data via the PDMP.